Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Brain Neoplasms × aumolertinib × Clear all

Phase

Status

Sponsor Class

OTHER 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Meningeal Carcinomatosis 1 Brain Neoplasms 1

Interventions

Radiosurgery 2 lithium sulfate 1 aumolertinib 1 Ultrasonography 1 Surgery, Computer-Assisted 1 Radiotherapy 1 Pliability 1 Metformin 1 Mental Status and Dementia Tests 1 Lithium 1 Hypoglycemic Agents 1 Exercise 1 Diet, Carbohydrate-Restricted 1 Blood Specimen Collection 1 Biguanides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04778800 2021-08-31

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Henan Cancer Hospital

Phase NA Unknown

Brain Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡